This inventor holds 2 USPTO granted patents. Top assignee: Fundacao Oswaldo Cruz-Fiocruz. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Vitor Francisco Ferreira: Innovator in Pharmaceutical Chemistry
Introduction
Vitor Francisco Ferreira is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating serious diseases. With a total of 2 patents, Ferreira's work is recognized for its potential impact on public health.
Latest Patents
Ferreira's latest patents focus on azole compounds used as tuberculostatic and leishmanicide agents. These inventions refer to new 1,2,3-triazole and imidazole compounds included in the families of compounds represented by general formula VIII. The patents also describe a pharmaceutical composition comprising at least one of the azole compounds represented by the general formula VIII, along with their use in the treatment or inhibition of tuberculosis and leishmaniasis.
Career Highlights
Vitor Ferreira is associated with the Fundação Oswaldo Cruz (Fiocruz), a prominent research institution in Brazil. His work at Fiocruz has allowed him to engage in groundbreaking research that addresses critical health issues. Ferreira's innovative approach to pharmaceutical development has positioned him as a key figure in his field.
Collaborations
Ferreira collaborates with esteemed colleagues, including Nubia Boechat and Marilia Dos Santos Costa. These partnerships enhance the research efforts at Fiocruz and contribute to the advancement of pharmaceutical sciences.
Conclusion
Vitor Francisco Ferreira is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for tuberculosis and leishmaniasis. His contributions are vital to improving health outcomes and advancing scientific knowledge in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile